WilliamYKimMD

Oncology • Chapel Hill, NC

Genitourinary Oncology, Hematologic Oncology

Professor, Medicine and Genetics, University of North Carolina at Chapel Hill School of Medicine

Join to view full profile

Dr. Kim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kim's full profile

Already have an account?

Office
101 Manning Dr
Chapel Hill, NC 27514
Phone+1 919-966-4996

Fax+1 919-843-5515

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1999 - 2002
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1996 - 1999
The Warren Alpert Medical School of Brown UniversityClass of 1996

Certifications & Licensure

NC State Medical License 2006 - 2025
MA State Medical License 1999 - 2006

Clinical Trials

Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate Cancer Start of enrollment: 2009 May 01
Completed
Phase 1
Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy Start of enrollment: 2012 Jun 01
Completed
Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer Start of enrollment: 2013 Oct 01
Terminated

Publications & Presentations

PubMed

1 citations
CAR-redirected natural killer T cells demonstrate superior antitumor activity to CAR-T cells through multimodal CD1d-dependent mechanisms.
Xin Zhou, Ying Wang, Zhangqi Dou, Gloria Delfanti, Ourania Tsahouridis
Nature Cancer. 2024-11-01
Renal Cell Carcinoma: A Review.
Tracy L Rose, William Y Kim
JAMA. 2024-09-24
3 citations
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma.
Andrea B Apolo, Karla V Ballman, Guru Sonpavde, Stephanie Berg, William Y Kim
The New England Journal of Medicine. 2024-09-15

Journal Articles

VHL Substrate Transcription Factor ZHX2 as an Oncogenic Driver in Clear Cell Renal Cell Carcinoma
Eric Jonasch, Xian Chen, William Y Kim, W Kimryn Rathmell, Science Magazine

Press Mentions

Review Highlights Advances in Kidney Cancer Research and CareAugust 28th, 2024
Newsworthy from the School of Medicine, Week of August 12 – 19August 18th, 2021
GeneCentric Therapeutics to Present New Analyses of Molecular Characterization and Prediction of Treatment Response in Patients with Muscle Invasive Bladder Cancer (MIBC)February 13th, 2020
Join now to see all